This study sought to determine if continuing preoperative aspirin therapy would increase the risk of bleeding complications in patients undergoing thyroid surgery.
A retrospective study, presented at ASH 2017, determined the effectiveness of aspirin in reducing risk of VTE in patients with multiple myeloma at high risk of developing VTE.
Study presented at the AASLD The Liver Meeting 2017 demonstrated the effect of regular aspirin use on risk of hepatocellular carcinoma in patients with chronic HBV.
Regular use of NSAIDs after diagnosis of colorectal cancer correlated with improved survival in survivors with KRAS wild-type tumors.
Regular aspirin use is associated with a lower risk of breast cancer among women with diabetes, a recent study from Taiwan has shown.
Researchers compared the effectiveness of NSAIDs, aspirin, and several nutritional supplements for the prevention of recurrent adenomatous neoplasia after colon polyp removal.
Aspirin's anti-inflammatory action is protective against another aggressive cancer: cholangiocarcinoma. Furthermore, it is beneficial regardless of daily use or dose.
Researchers revealed a pathway in cell culture and mice by which salicylic acid decreases inflammation and by which salicylic acid and diflunisal decrease cancerous growth.
Greatest survival benefit observed for those taking the drug before their cancer diagnosis.
A low-dose of aspirin could increase survival by up to 20% and help stop metastasis for patients receiving cancer treatment.
USPSTF Releases Updated Recommendations for Aspirin Use to Prevent Cardiovascular Disease and Colorectal CancerApril 18, 2016
The US Preventive Services Task Force (USPSTF) updated its recommendations on low-dose aspirin use for the primary prevention of CVD and the use of aspirin and NSAIDs for prevention of CRC.
Regular, low doses of aspirin for a minimum of 6 years correlated with a small, yet significant reduction in overall cancer risk, due primarily to reductions in risks for colorectal cancer and gastrointestinal cancer.
The anti-cancer effect of low-dose aspirin was seen most strongly with colon and gastrointestinal tumors.
The risk of lethal prostate cancer, but not of overall, high-grade, or advanced cancers, was reduced with regular aspirin use.
Aspirin improves survival in patients with tumors situated throughout the gastrointestinal (GI) tract, according to results from a large study. This is the first time that survival data from patients with tumors in different GI locations have been analyzed at the same time.
A regular regimen of aspirin can reduce additional cancer risk for obese individuals, according to study data.
Regular aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may lower the long-term risk of colorectal cancer (CRC), new study data suggests.
Taking aspirin regularly can negate the increased the risk for developing colorectal cancer in patients with Lynch syndrome.
Aspirin exposure after a colorectal cancer diagnosis was independently associated with improved colorectal cancer-specific survival.
Post-diagnostic aspirin use is not associated with a decreased risk of prostate cancer outcomes, according to study data.
Taking aspirin regularly may help prevent gastrointestinal cancers, a new study suggests, with the greater benefit seen when taking it over many years.
More than 10% of patients are inappropriately taking aspirin for primary prevention of cardiovascular disease.
A recent meta-analysis demonstrated an association between aspirin and a reduced risk of prostate cancer.
Even a small daily dose of aspirin may help lower mortality among men with nonmetastatic prostate cancer, according to research.
Aspirin and other other NSAIDs were associated with a decreased risk for developing an aggressive form of prostate cancer.
Recurrence of hormone-related breast cancer was reduced by 50% in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), according to newly published data.
Daily aspirin appears beneficial for men and women between ages 50 and 65 in the general population.
In a recent study, researchers found that by taking a daily aspirin, the incidence of gastrointestinal cancers is reduced, as well as a reduction in cancer-specific mortality.
Guidelines from the Fred Hutchinson Cancer Research Center advise that low-dose daily aspirin for prevention of pancreatic cancer may not be for everyone.
Researchers from the University of Basel were able to show that aspirin use and smoking both influence aging processes of the female genome that are connected to colorectal cancer.
Sign Up for Free e-newsletters
- Physical Inactivity Linked With Increased Risk of Hodgkin, Non-Hodgkin Lymphoma
- Challenges for Young Adult Couples Facing a Cancer Diagnosis
- Progression-Free Survival Extended With PANEX Protocol in R/R Multiple Myeloma
- Following ACS Guidelines Shown to Improve Outcomes for Colon Cancer Survivors
- In Older Women With Breast Cancer QoL May Predict 10-Year Mortality
- Letter-Writing Project Communicates Care Wishes to Healthcare Team, Family
- Pivot Nurse Improves Patients' Navigation Through Lung Cancer Care
- Long-term Carfilzomib May Be Safe, Effective In Relapsed Multiple Myeloma
- Palliative Sedation a Valid Option for Refractory Symptoms in End-stage Cancer
- Testicular Cancer Treatment May Increase Risk for Heart Disease in Survivors
- Spotlight on Triptorelin in the Treatment of Premenopausal Women with Early-Stage Breast Cancer
- Redefining Prognosis for Hematologic Cancers in Older Adults by Age
- Outcomes for Elderly With Hematologic Cancers Effected by Cognitive Impairments
- Evolving Role of Radiation Therapy in the Treatment of Mesothelioma
- FDA Approves Fostamatinib for ITP After Insufficient Response to Previous Treatment
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|